January 12, 2017
Aspen Japan has been receiving more-than-expected orders for its authorized generic (AG) version of GlaxoSmithKline’s migraine therapy Imigran (sumatriptan), which is to be rolled out on January 16. The company started taking orders at the end of last year, exceeding...read more